JP
BIIB icon

John Paulson’s Biogen BIIB Stock Holding History

John Paulson’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-17,300
Closed -$4.73M – 112
2017
Q1 		$4.73M Sell
17,300
-34,900
-67% -$9.87M 0.06% 74
2016
Q4 		$14.8M Sell
52,200
-255,800
-83% -$75.8M 0.19% 58
2016
Q3 		$96.4M Buy
308,000
+184,900
+150% +$54.8M 1.04% 20
2016
Q2 		$29.8M Buy
123,100
+4,700
+4% +$1.24M 0.3% 43
2016
Q1 		$30.8M Buy
118,400
+82,200
+227% +$21.7M 0.23% 46
2015
Q4 		$11.1M Buy
+36,200
New +$10.4M 0.07% 49

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

John Paulson's BIIB Position: Q2 2017 in Review

John Paulson sold out of Biogen (BIIB) in Q2 2017, closing a stake of 17,300 shares — an estimated $4.73M sold.

John Paulson first reported a position in BIIB in Q4 2015 and held it in 6 quarters. The position peaked at $96.4M in Q3 2016. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • John Paulson reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • John Paulson sold 17,300 Biogen shares in Q2 2017, an estimated $4.73M.
  • John Paulson first reported a position in Biogen in Q4 2015 and held it in 6 quarters.
  • John Paulson's Biogen position peaked at $96.4M in Q3 2016.
  • 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Paulson & Co's 13F filing for Q2 2017, filed 14 Aug 2017.